Table 1.
Time course change of hematological parameters.
| Baseline (n=29) |
First follow-up (n=29) |
Second follow-up (n=14) |
||||
|---|---|---|---|---|---|---|
| Blood cell type | Mean | SD | Mean | SD | Mean | SD |
| WBC*† | 9.4 | (5.2) | 6.4 | (6.0) | 5.7 | (1.4) |
| RBC*† | 4.4 | (0.6) | 4.0 | (0.5) | 3.9 | (0.6) |
| Hemoglobin*† | 12.9 | (1.8) | 12.0 | (1.6) | 12.3 | (1.6) |
| Hematocrit*† | 38.6 | (4.5) | 35.8 | (4.2) | 36.4 | (4.0) |
| Platelet* | 269.6 | (72.5) | 227.5 | (53.5) | 221.0 | (60.8) |
| Neutrophil*† | 6.8 | (4.7) | 5.2 | (6.2) | 4.0 | (1.8) |
| Lymphocyte*† | 1.8 | (1.3) | 0.7 | (0.3) | 0.8 | (0.5) |
| Monocyte* † | 0.7 | (0.3) | 0.5 | (0.2) | 0.4 | (0.2) |
Overall CBC significantly decreased after treatment. CBC excepting for hemoglobin kept significant low level on the second follow-up. Lymphocyte showed the greatest decline after treatment.
* Baseline of CBC (WBC, RBC, hemoglobin, Hematocrit, Platelet, Neutrophil, Lymphocyte, and Monocyte) significantly decreased compared with first follow-up (p < 0.05).
†Baseline of CBC (WBC, RBC, hemoglobin, Hematocrit, Neutrophil, Lymphocyte, and Monocyte) significantly decreased compared second follow-up (p < 0.05).